Sweat may pass on hepatitis B in contact sports

Sweat may be another way to pass on hepatitis B infection during contact sports, suggests research published ahead of print in the British Journal of Sports Medicine.

Hepatitis B virus attacks the liver and can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death.

The research team analysed blood and sweat samples from 70 male Olympic wrestlers for evidence of hepatitis B infection (HBV).

The wrestlers, who were all aged between 18 and 30, were all asked about injuries, as blood-borne infection is a common route of transmission.

Over a third said they had had bleeding or weeping wounds during training and competition. And almost half said that they had had an episode of bleeding during other activities.

None of the wrestlers had active HBV infection, as evidenced by a lack of antibodies to the virus.

Nevertheless, the virus itself was found in the blood of nine (13%), suggesting that they had hidden or occult infection, says the author. This is perfectly plausible, given that intense training temporarily suppresses a normal immune response, she says.

Eight (11%) also had particles of the virus present in their sweat, and levels of the virus found in the blood closely matched those found in the sweat.

The findings prompt the author to suggest that sweat, like open wounds and mucous membranes, could be another way of transmitting the infection.

Some sporting bodies have ruled that HIV testing should be mandatory for all contact sport competitors, but no such recommendations have been made for HBV, says the author.

Yet HBV is far more transmissible, because much higher levels of the virus are found in the blood and it is not as fragile as HIV, she says, calling for HBV testing and vaccination for all wrestlers at the start of their career.

Source: BMJ Specialty Journals

Related stories:

Virus weaves itself into the DNA transferred from parents to babies
Parents expect to pass on their eye or hair color, their knobby knees or their big feet to their children through their genes. But they don't expect to pass on viruses through those same genes.
Early treatment is key to combating hepatitis C virus
Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a rapid poly-functional immune response against HCV similar to when infection is erradicted spontaneously, according to a new study published in the Journal of Virology. Therefore, early treatment can restore immune response against HCV and help eliminate the virus rapidly. This new discovery of the mechanisms of viral eradication could contribute to the development of new treatments.
Structure of hepatitis B virus mapped
Using a newly developed method, Utrecht University researchers have mapped the structure and composition of the hepatitis B virus. The researchers were able to map the structure by spraying the virus.
Researchers disprove long-standing belief about HIV treatment
Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail."
Improved culture system for hepatitis C virus infection
A University of California, San Diego School of Medicine researcher has developed the first tissue culture of normal, human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment to evaluate possible treatments. The novel cell line, described in the July 16 issue of PLoS ONE, will allow pharmaceutical companies to effectively test new drug candidates or possible vaccines for the HCV infection, which afflicts about 170 million people worldwide. Currently, there is no animal model that is effective for testing such therapies.
Hepatitis C virus may need enzyme's help to cause liver disease
A key enzyme may explain how hepatitis C infection causes fatty liver – a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers.
Researchers find smallpox drug may also target adenovirus
Scientists at Saint Louis University have made two key discoveries that could lead to the first-ever human testing of a drug to target the adenovirus, which causes a number of severe upper-respiratory infections and is one of many viruses that causes the common cold.
Team develops safe, effective RNA interference technique
A team of researchers from MIT and Alnylam Pharmaceuticals has developed safe and effective methods to perform RNA interference, a therapy that holds great promise for treating a variety of diseases including cancer and hepatitis.

News discussion:

Medicine & Health news